Innovation and Quality System
Commitment to innovation
We have been collaborating with Parc Científic de Barcelona (UB) since 2019 with the aim of making progress by offering new and better products that help preventing infections, providing greater efficacy, and easy to use.
During 2021 Vesismin Health launched 3 in-house R&D products on the market. Our R&D department is highly committed to the continuous improvement day by day.
Vesismin Health has always been firmly committed to quality. This is and will continue to be our goal.
Our production plant exceeds all the applicable quality standards:
Our quality system is certified according to ISO 9001 and ISO 13485 requirements, which guarantees the quality of the manufactured batches and their traceability from the raw material to the end-user.
Our antisepsis and disinfection products in the clinical field are approved by the Spanish Agency of Medicines and Health Products (AEMPS), the remaining health products are controlled by an independent body, upholding European regulations.
All our products comply with the Spanish and European regulation of biocides and medical devices.
Si quiere conocer la Política de Calidad de Vesismin Health, click here
We have a high commitment and responsibility towards society. We are firmly committed to its employees and the community, as well as to the environment. Innovation and excellence, transparency and honesty have always been part of our social commitment. We strive every day to create a happy company, providing value to our customers, employees, investors and society as a whole.
Vesismin is committed to promote projects that help improving people’s quality of life in vulnerable situations, which is why every year we collaborate locally in social projects.
We contributed helping the following entities: Banco de Alimentos, Marató de TV3, Farma Mundi, Amics de l’Hospital del Mar, Centre d’Acollida Assís and Damnificados por el volcán de La Palma.
We provide an external ethics communication channel (Corporate-Ethic Line) in order to give the opportunity to report any possible indication, knowledge or suspicion of non-compliance with applicable regulations, or any other irregularity that could be considered relevant to comply with and follow the entity’s Commitment to Ethics and Regulatory Compliance. More info